-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, ETruPgK5Vs+UYOb1X2KtCPHpjP1zDb7YVS6KGp6YUnBLQ3OVmvWTmVI3pyMRO2FK SYiFcpwpq1E+oILQwob0vw== 0000899681-00-000245.txt : 20000924 0000899681-00-000245.hdr.sgml : 20000924 ACCESSION NUMBER: 0000899681-00-000245 CONFORMED SUBMISSION TYPE: 424B3 PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20000707 FILER: COMPANY DATA: COMPANY CONFORMED NAME: ALLIANCE PHARMACEUTICAL CORP CENTRAL INDEX KEY: 0000736994 STANDARD INDUSTRIAL CLASSIFICATION: 2835 IRS NUMBER: 141644018 STATE OF INCORPORATION: NY FISCAL YEAR END: 0630 FILING VALUES: FORM TYPE: 424B3 SEC ACT: SEC FILE NUMBER: 333-33242 FILM NUMBER: 669456 BUSINESS ADDRESS: STREET 1: 6175 LUSK BLVD CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: 8584105200 MAIL ADDRESS: STREET 1: 617 LUSK BLVD CITY: SAN DIEGO STATE: CA ZIP: 92121 FORMER COMPANY: FORMER CONFORMED NAME: OTISVILLE BIOPHARM INC DATE OF NAME CHANGE: 19890310 FORMER COMPANY: FORMER CONFORMED NAME: OTISVILLE BIOTECH INC DATE OF NAME CHANGE: 19861216 POS AM 1 0001.htm POS AM
Prospectus Supplement No. 1, dated July 7, 2000,
to Prospectus, dated June 30, 2000.		 Rule 424(c)    
File No. 333-33242    

ALLIANCE PHARMACEUTICAL CORP.

Common Stock

        This prospectus supplement relates to the public offering of shares of our common stock by the selling shareholders named in the prospectus referenced above.

         The Selling Shareholder Table is modified to correct the names of two selling shareholders. The correct names of the selling shareholders are Brown Simpson Strategic Growth Fund, Ltd. and Brown Simpson Strategic Growth Fund, L.P. and not Brown Simpson Strategic Value Fund, Ltd. and Brown Simpson Strategic Value Fund, L.P.

 -----END PRIVACY-ENHANCED MESSAGE-----